Form 4 holding
Director
BioAge Labs, Inc.
- Security class
- Common Stock
- Shares / value
- 1,269,072
- Estimated value
- $22,843,296
- Report date
- 01 Oct 2024
- Price
- $18.00
- Ownership
- AH Bio Fund I, L.P.
Vijay Satyanand Pande - Director at BioAge Labs, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- BIOA on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Vijay Satyanand Pande since 28 Sep 2025
Reported holdings for Vijay Satyanand Pande in BioAge Labs, Inc.
Form 4 holding
Director
BioAge Labs, Inc.
- Security class
- Common Stock
- Shares / value
- 1,119,195
- Estimated value
- $20,145,510
- Report date
- 03 Oct 2024
- Price
- $18.00
- Ownership
- Andreessen Horowitz LSV Fund III, L.P.
Form 4 holding
Director
BioAge Labs, Inc.
- Security class
- Common Stock
- Shares / value
- 655,294
- Estimated value
- $11,795,292
- Report date
- 01 Oct 2024
- Price
- $18.00
- Ownership
- AH Bio Fund IV, L.P.
Form 4 holding
Director
BioAge Labs, Inc.
- Security class
- Common Stock
- Shares / value
- 189,609
- Estimated value
- $3,412,962
- Report date
- 01 Oct 2024
- Price
- $18.00
- Ownership
- AH Bio Fund III, L.P.
Form 4 holding
Director
BioAge Labs, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 22,000
- Estimated value
- Report date
- 10 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
BioAge Labs, Inc.
- Security class
- Series A-1 Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 27 Sep 2024
- Price
- Ownership
- AH Bio Fund I, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
BioAge Labs, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 27 Sep 2024
- Price
- Ownership
- AH Bio Fund I, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
BioAge Labs, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 27 Sep 2024
- Price
- Ownership
- AH Bio Fund III, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
BioAge Labs, Inc.
- Security class
- Series D Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 27 Sep 2024
- Price
- Ownership
- AH Bio Fund IV, L.P.
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Vijay Satyanand Pande in BioAge Labs, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.